pipette
ESEspañol

PINK1-mediated mitophagy supports lung cancer initiation and limits the efficacy of KRAS -targeted therapy

Diogo Gonçalvès, Emma Guilbaud, Léa Di Mascio, Camille Guerrier, Linda Mejri, Sonia Núñez‐Vázquez, Lucie Levasseur, Rachel Paul, Corinne Ménigot, Christophe Bontoux, Guylène Rignol, Véronique Hofman, Paul M Hofman, Marin Truchi, Bernard P. Mari, Laurent Yvan‐Charvet, Johanna Chiche, Sandrine Marchetti, Jean‐Ehrland Ricci

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Together, our findings identify PINK1-dependent mitophagy as an early vulnerability in KRAS -driven lung cancer and provide a rationale for targeting mitophagy to improve the efficacy of KRAS -targeted therapies.

Appeared: Sunday, October 18. Science Advances. Peer-reviewed journal.

DOI: 10.1126/sciadv.aef8820